Overexpression of IL-33 has been associated with chemotherapy resistance, migration, and metastasis in various cancers [11], and IL-33 can promote lung tumorigenesis and metastasis via type 2 innate lymphoid cells (ILC2s) [12]. This evidence concerns the gene IL33 and cancer.